Bevacizumab in the treatment of HER2-negative breast cancer
Vito LorussoOncologic Institute, Vito Fazzi Hospital, Lecce, ItalyAbstract: Angiogenesis has a clear and definite role in the breast cancer progression process, making antivascular endothelial growth factor (VEGF) therapies an attractive option for the treatment of metastatic breast cancer (MBC). Be...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2008-11-01
|
| Series: | Biologics: Targets & Therapy |
| Online Access: | http://www.dovepress.com/bevacizumab-in-the-treatment-of-her2-negative-breast-cancer-a2633 |